1.Capitanio U, Montorsi F: Renal cancer. Lancet 2016, 387(10021):894–906.
2.Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F: International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality. Eur Urol 2014.
3.Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S: Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol 2016.
4.Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, Tian Z, Schmitges J, Graefen M, Perrotte P et al: Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 2012, 23(4):973–980.
5.RR M, D B, TK C: Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2018, undefined(undefined):JCO2018790253.
6.Petteys RJ, Spitz SM, Rhee J, Goodwin CR, Zadnik PL, Sarabia-Estrada R, Groves ML, Bydon A, Witham TF, Wolinsky JP et al: Tokuhashi score is predictive of survival in a cohort of patients undergoing surgery for renal cell carcinoma spinal metastases. Eur Spine J 2015, 24(10):2142–2149.
7.Han S, Wang T, Jiang D, Yu Y, Wang Y, Yan W, Xu W, Cheng M, Zhou W, Xiao J: Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases. Eur Spine J 2015.
8.Tatsui CE, Suki D, Rao G, Kim SS, Salaskar A, Hatiboglu MA, Gokaslan ZL, McCutcheon IE, Rhines LD: Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma. Journal of neurosurgery Spine 2014, 20(1):108–116.
9.Fukushima H, Hozumi T, Goto T, Nihei K, Karasawa K, Nakanishi Y, Kataoka M, Tobisu KI, Koga F: Prognostic significance of intensive local therapy to bone lesions in renal cell carcinoma patients with bone metastasis. Clin Exp Metastasis 2016.
10.Kume H, Kakutani S, Yamada Y, Shinohara M, Tominaga T, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H et al: Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? J Urol 2011, 185(5):1611–1614.
11.Toyoda Y, Shinohara N, Harabayashi T, Abe T, Akino T, Sazawa A, Nonomura K: Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol 2007, 52(1):163–168.
12.Ruatta F, Derosa L, Escudier B, Colomba E, Guida A, Baciarello G, Loriot Y, Fizazi K, Albiges L: Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre. European journal of cancer 2019, 107:79–85.
13.Langerhuizen DW, Janssen SJ, van der Vliet QM, Raskin KA, Ferrone ML, Hornicek FJ, Schwab JH, Lozano-Calderón SA: Metastasectomy, intralesional resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma. J Surg Oncol 2016.
14.Kato S, Murakami H, Demura S, Nambu K, Fujimaki Y, Yoshioka K, Kawahara N, Tomita K, Tsuchiya H: Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up. J Surg Oncol 2016, 113(5):587–592.
15.Xiong W, Xu Y, Fang Z, Li F: Total En Bloc Spondylectomy for Lumbar Spinal Tumors by Paraspinal Approach. World Neurosurg 2018.
16.Kawahara N, Tomita K, Murakami H, Demura S: Total en bloc spondylectomy for spinal tumors: surgical techniques and related basic background. Orthop Clin North Am 2009, 40(1):47–63, vi.
17.Jia Q, Chen G, Cao J, Yang X, Zhou Z, Wei H, Liu T, Xiao J: Clinical Features and Prognostic Factors of Pediatric Spine Giant Cell Tumors: report of 31 clinical cases in a single center. Spine J 2019.
18.T H, N Y, K H, A T, K A, Y T, S K, H M, H T: Long-term patient survival after the surgical treatment of bone and soft-tissue metastases from renal cell carcinoma. The bone & joint journal 2018, null(9):1241–1248.